Month: December 2015

A well-known Tampa law firm respected for its achievements in pharmaceutical and personal injury litigation, Frank Charles Miranda, P.A. is pleased to launch a new information center within its website, https://www.fcmlaw.com/defective-drugs/xarelto/. By providing residents Tampa and St. Petersburg comprehensive information on the risk of internal bleeding for people who take Xarelto, the accumulated articles and responses to frequently asked questions…

Xarelto is a Factor Xa inhibitor that was initially released to combat deep vein thrombosis (DVT) which can lead to a pulmonary embolism when a hip or knee joint is replaced. Unlike the tailored dosage of a drug Warfarin, Xarelto is designed to be given to patients in a one size fits all dose. A common adverse reaction to Xarelto…